About
Neurotronic is developing an investigational multi-organ denervation therapy called Neuviant™ designed to reduce blood sugar and blood pressure simultaneously in patients with uncontrolled type 2 diabetes and hypertension by targeting overactive sympathetic nerves near the kidneys and liver.
Explore Neurotronic's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.